miR-142-3p as Potential Biomarker of Synaptopathy in MS

NCT03999788 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Neuromed IRCCS